The largest database of trusted experimental protocols

8 protocols using toremifene

1

Estrogen Receptor Library Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Most compounds used in the estrogen receptor library screen were synthesized in-house and have been reported.32 (link)–35 (link), 56 (link), 57 (link) Toremifene, tamoxifen, raloxifene, bazedoxifene, ospemifene, ridaifen-B, nafoxidine, RAD-1901, MPP, acolbifene, and compound 7 were purchased from Sigma-Aldrich or Med Chem Express. All compounds were dissolved in DMSO at a final concentration of 10 mM and were stored at −20 °C until use.
+ Open protocol
+ Expand
2

Endoxifen Hydrochloride Pharmacological Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Z-Endoxifen hydrochloride (ENDX·HCl) was provided by the Developmental Therapeutics Program, NCI. TAM, 4HT, N-desmethyltamoxifen (NDMT), and toremifene (a selective ER modulator used as the internal standard) were purchased from Sigma Chemical Company (St. Louis, MO). The primary stock solutions of ENDX (2 mg/ml), 4HT (1 mg/ml), NDMT (1 mg/ml), TAM (1 mg/ml), and toremifene (1 mg/ml) were prepared in ethanol and stored at −20 °C. Working standard solutions were prepared in ethanol and stored at −20 °C. All animal studies were performed under protocols and guidelines approved by the Institutional Animal Care and Use Committee of the Mayo Clinic (Rochester, MN). Female CD1 mice were supplied by Charles River (Portage, MI). Female ovariectomized BALB/c athymic nude mice were obtained from Harlan Laboratories (Indianapolis, IN). The mice were housed in the Department of Comparative Medicine Animal Facility, which provided a pathogen-free environment under controlled conditions of light and humidity, and accredited by the International Association for Assessment and Accreditation of Laboratory Animal Care. Mice were acclimatized for 48 h after arrival and received food and water ad libitum.
+ Open protocol
+ Expand
3

Viral Inhibition Assay with Toremifene

Check if the same lab product or an alternative is used in the 5 most similar protocols
rVSV-GP(WT), VSV-GP(R64A), and rVSV-GP(R64A) second-site revertants were incubated with a dilution series of toremifene (Sigma-Aldrich, St. Louis, MO), starting at 30 μM (second-site revertants) or 4 μM [VSV-GP(R64A)], at room temperature for 2 h. The virus-drug mixture was then added to Vero cells and cultured as described above, and infection was allowed to proceed at 37°C for 1 h before addition of 20 mM NH4Cl. Following 14 h of incubation at 37°C, infection was scored by automated counting of GFP-positive cells as described above. After normalization of infection levels using DMSO-treated virus as a control, significance was calculated from two independent experiments, each comprising three technical replicates, using two-way ANOVA with the Šidák correction for multiple comparisons (*, P < 0.033; **, P < 0.002; ***, P < 0.001).
+ Open protocol
+ Expand
4

Pharmacological Inhibitors of Virus Entry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stock solutions of drugs were prepared in dimethyl sulfoxide (DMSO) and stored as frozen aliquots until use. Cells were incubated with 3.47 (Microbiotix), amiodarone (Sigma), bepridil (Sigma), clomifene (Sigma), sertraline (Toronto Research Chemicals), or toremifene (Sigma) for 1 h or 16 h at 37°C with concentrations as indicated. Incubation of cells with E-64d (Peptides International) was extended to 6 h at 37°C, while cells were not preincubated with U18666A (Calbiochem) for PLA, but preincubated for 1 h or 16 h at 37°C for additional described experiments at concentrations indicated. Inhibitors were maintained at the same concentrations during virus spinoculation and virus entry into cells.
+ Open protocol
+ Expand
5

Ligand Binding and Functional Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
All SERMs were obtained from the following commercial sources. tamoxifen and Y-134 were purchased from Tocris Bioscience (Bristol, United Kingdom). N-desmethyl tamoxifen, 4-hydroxy tamoxifen, endoxifen, SO4-tamoxifen, toremifene, 4-hydroxy toremifene, OSP, RAL, lasofoxifene, NAF, and BAZ were all obtained from Sigma Aldrich (St. Louis, MO, USA). Acolbifene was procured from AdooQ Bioscience (Irvine, CA, USA).
AM-630, AM-251, DAMGO, and WIN-55,212-2 were purchased from Tocris Bioscience. CP-55,940 was obtained from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). [35S]GTPγS (1250 Ci/mmol) was procured from American Radiolabeled Chemicals (St. Louis, MO, USA) and [3H]CP-55,940 (131.4 Ci/mmol) was purchased from PerkinElmer (Waltham, MA, USA).
All other reagents were purchased from Fisher Scientific Inc. (Pittsburgh, PA, USA). All compounds were dissolved in 100% DMSO to produce a stock concentration of 10 mM.
+ Open protocol
+ Expand
6

Quantitative Analysis of SERMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tamoxifen, toremifene and afimoxifene were purchased from Sigma–Aldrich (St. Louis, MO, USA). Droloxifene, lasofoxifene and nafoxidine were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Acetonitrile of LC‒MS grade was purchased from Sigma–Aldrich. Ultrapure deionized water was obtained from a Milli-Q water system from Millipore (Bedford, MA, USA).
+ Open protocol
+ Expand
7

Screening Compounds for Gb3 Reduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were used to perform the assays: Tamoxifen (10 µM, SIGMA 3–48 h), Toremifene (10 µM, SIGMA 48 h) and Ospemifene (10 µM, SIGMA 48 h).
Screening and dose‐response: Cells were plated on 384‐well plates (2 × 104 cells per well). After 24 h, cells were treated with 10 µM compounds or 0.1% dimethyl sulfoxide (DMSO) in complete medium. The Prestwick Library consists of 1,280 FDA‐approved drugs, all off‐patent, dissolved in DMSO. The drugs from the 96‐well source plate were diluted and compacted in 384‐well plates to a concentration of 100 μM in the DMEM medium (working plate). To study the effect of the drugs, 5 μl of the drugs at 100 μM in DMEM medium were added to plates containing 45 μl of medium (10 μM final drug concentration with 0.1% DMSO). As a positive control of Gb3 reduction, we used the glucosylceramide synthase inhibitor PDMP.
For the dose–response confirmation test, compounds were serially diluted from 10 mM stock into complete medium and added to plates starting at 30 to 0.1 µM. The final concentration of DMSO did not exceed 0.3% in the dose–response assays.
Cells were incubated together with drugs 48 h at 37°C and 5% CO2.
+ Open protocol
+ Expand
8

Breast Cancer Cell Line Culture and Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Breast cancer cell lines MCF7 and Bcap37 were purchased from the Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China. Both cell lines were ER positive. Cells were grown in normal DMEM with 10% FBS, 100 unit/mL penicillin and 100 µg/mL streptomycin. Prior to all experiments, cells were pretreated for at least 1 week with an estrogen-free medium (phenol red-free DMEM with 10% dextran-coated charcoal serum, 100 units/mL penicillin, 100 µg/mL streptomycin, 0.5 mM sodium pyruvate, and 2 mM l-glutamine) to prevent the effects of serum-derived estrogenic compounds. Cell transfection was carried out using Lipofectamine 2000 (Cat. 11668, Invitrogen) according to the manufacturer's instructions.
E2 (E8875, Sigma) was prepared as a 10 mM solution with ethanol and stored at −80°C. Tamoxifen (T5648, Sigma) or toremifene (T7204, Sigma) was dissolved in 10 mM DMSO. Phps1 (P0039, Sigma,) was dissolved in PBS solution. NSC87877 (565851, Millipore) and phps4 (a gift from Dr. Yuehai Ke (Department of Medicine, Zhejiang University) were dissolved in DMSO. Plasmids expressing siRNAs of Shp2 Plvth-H1, Plvth-H2, and Plvth-H3, as well as a control plasmid Plvth were also prepared as previously described [53] (link). Unless otherwise indicated, all other chemicals were obtained from Sigma/Fisher.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!